Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis

Alsya J Affandi, Joel A G van Roon

Research output: Contribution to journalArticleAcademic

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)2571-2574
Number of pages4
JournalArthritis & Rheumatology
Issue number11
Publication statusPublished - Nov 2016
Externally publishedYes


  • Cytokines
  • Humans
  • Receptors, Cytokine
  • Scleroderma, Systemic

Cite this